For investors seeking broad exposure to U.S. small-cap equities, the Schwab U.S. Small-Cap ETF (SCHA) and the iShares Morningstar Small-Cap ETF (ISCB) present a compelling, yet nuanced, choice. Both funds boast a low expense ratio of 0.04%, but their divergence lies in their sector tilts, assets under management, trading volume, and historical risk profiles, ultimately making the decision hinge on an investor’s sector preferences and their tolerance for potential drawdowns.
Key Differentiators Emerge
While both SCHA and ISCB aim to capture the performance of the U.S. small-cap segment, a closer examination reveals significant differences. SCHA, managed by Schwab, stands out with a substantially larger asset base, holding $22.0 billion in assets under management (AUM), and exhibits higher trading volume. This scale and liquidity may appeal to institutional investors or those prioritizing ease of trading. In contrast, ISCB, an iShares product, manages a more modest $268.5 million in AUM.
Performance metrics also show a divergence. As of April 22, 2026, SCHA delivered a stronger 1-year total return of 47.1%, outpacing ISCB’s 38.4%. However, ISCB offers a marginally higher dividend yield of 1.3% compared to SCHA’s 1.1%. In terms of risk, ISCB has demonstrated a slightly smaller maximum drawdown over the past five years, registering -29.94% against SCHA’s -30.78%. This suggests ISCB may offer a marginally smoother ride during significant market downturns.
Sector Allocation: A Tale of Two Tilts
The most significant strategic difference between SCHA and ISCB lies in their sector allocations. ISCB places a greater emphasis on the Healthcare and Industrials sectors, with recent reports indicating allocations of 14% and 18% respectively. Financial Services also represents a notable 16% of its portfolio. This tilt could be attractive to investors looking to overweight these sectors or seeking diversification away from technology-heavy portfolios.
SCHA, on the other hand, exhibits a more pronounced tilt towards the Technology sector, accounting for 18% of its holdings. It also maintains significant weights in Financial Services and Industrials, each at 16%. This leaning into technology could be a deciding factor for investors who believe in the continued growth prospects of the tech industry within the small-cap space.
Portfolio Composition and History
Both ETFs offer broad diversification within the small-cap universe. ISCB tracks a mix of 1,554 stocks, with its largest holdings, such as Lumentum Holdings Inc (NASDAQ:LITE), Revolution Medicines Inc (NASDAQ:RVMD), and Albemarle Corp (NYSE:ALB), each representing a small fraction of the overall assets. The fund boasts a long track record, having been in existence for nearly 22 years.
SCHA, with 1,729 holdings, offers slightly broader diversification. Its top holdings include Sandisk Corp (NASDAQ:SNDK), Lumentum Holdings Inc (NASDAQ:LITE), and Revolution Medicines Inc (NASDAQ:RVMD). The near-identical top holdings in Lumentum and Revolution Medicines suggest some overlap in their underlying stock selection, despite their differing sector emphases.
Investor Considerations: Risk Tolerance and Sector Conviction
When comparing two low-cost ETFs tracking the same market segment, the decision often boils down to an investor’s conviction in the specific vehicle and their strategic objectives. The modest performance gap observed over five years—a $41 difference on a $1,000 investment—suggests neither fund has demonstrated a definitive structural edge over the other in terms of pure returns.
The primary driver for selection should be the investor’s outlook on specific sectors and their capacity to weather market volatility. For investors already heavily exposed to technology, ISCB’s tilt towards Healthcare and Industrials could provide valuable diversification. Conversely, those bullish on technology’s long-term prospects within the small-cap space might favor SCHA’s heavier allocation.
Ultimately, the question of whether to choose SCHA or ISCB transcends mere performance metrics. It delves into an investor’s fundamental approach to risk. A maximum drawdown of around 30% is a significant event in any market cycle. Investors who view such volatility not as a threat to be exited, but as an opportunity to potentially buy into undervalued assets, are likely to derive greater benefit from either ETF, regardless of its specific sector leanings.
